Wells Fargo & Company Cuts Mettler-Toledo International (NYSE:MTD) Price Target to $1,350.00

Mettler-Toledo International (NYSE:MTD - Get Free Report) had its price target dropped by equities researchers at Wells Fargo & Company from $1,400.00 to $1,350.00 in a report released on Monday,Benzinga reports. The firm currently has an "equal weight" rating on the medical instruments supplier's stock. Wells Fargo & Company's price target suggests a potential upside of 7.99% from the company's current price.

A number of other analysts also recently commented on MTD. Stifel Nicolaus increased their price target on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a "buy" rating in a research report on Monday, August 5th. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating on the stock in a report on Monday. JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a "neutral" rating in a report on Monday, August 5th. Finally, Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an "in-line" rating in a research note on Tuesday, October 1st. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Mettler-Toledo International has a consensus rating of "Hold" and a consensus price target of $1,338.75.

Mettler-Toledo International Trading Down 4.6 %

Shares of NYSE:MTD traded down $59.96 during mid-day trading on Monday, hitting $1,250.07. 295,697 shares of the company traded hands, compared to its average volume of 134,156. The stock has a market cap of $26.53 billion, a P/E ratio of 34.44, a P/E/G ratio of 3.83 and a beta of 1.16. The stock has a 50-day moving average price of $1,398.01 and a two-hundred day moving average price of $1,402.52. Mettler-Toledo International has a 12-month low of $1,015.29 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 532.25%. The firm had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. As a group, analysts expect that Mettler-Toledo International will post 40.34 earnings per share for the current year.

Insider Activity

In related news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the completion of the transaction, the insider now directly owns 734 shares in the company, valued at approximately $1,044,459.98. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.94% of the company's stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of large investors have recently modified their holdings of MTD. EverSource Wealth Advisors LLC increased its position in shares of Mettler-Toledo International by 8.0% in the first quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier's stock worth $117,000 after purchasing an additional 7 shares during the last quarter. UMB Bank n.a. raised its position in shares of Mettler-Toledo International by 6.6% during the 2nd quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier's stock valued at $158,000 after buying an additional 7 shares in the last quarter. Bellevue Group AG raised its position in shares of Mettler-Toledo International by 32.0% during the 1st quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier's stock valued at $44,000 after buying an additional 8 shares in the last quarter. Massmutual Trust Co. FSB ADV grew its position in Mettler-Toledo International by 7.2% in the second quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier's stock worth $166,000 after acquiring an additional 8 shares in the last quarter. Finally, DT Investment Partners LLC increased its stake in Mettler-Toledo International by 13.3% in the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier's stock valued at $102,000 after acquiring an additional 8 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.